サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386934

静注用免疫グロブリンの世界市場：動向、予測、競合分析（～2030年）

Intravenous Immunoglobulin Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

静注用免疫グロブリンの世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

静注用免疫グロブリンの動向と予測

世界の静注用免疫グロブリンの市場規模は、2024～2030年にかけてCAGR 7.6%で成長し、2030年までに約246億米ドルに達すると予測されています。この市場の主な促進要因は、高齢者人口の増加、血友病患者の増加、免疫グロブリンの生成に関する新技術、精製方法の改善（血漿収率の向上）です。世界の静注用免疫グロブリン市場の将来は、病院、在宅医療、専門クリニックの各市場におけるビジネスチャンスで有望視されています。

静注用免疫グロブリン市場の洞察

Lucintelの予測によると、免疫不全症は、個々の患者に基づいた診断と治療への注目が高まっていることと、患者のほとんどが自己投与に適応できないため、患者のトレーニングが必要であることから、予測期間中も最大セグメントであり続けるという。

この市場において、病院が最大のセグメントであり続けると思われます。これは、原発性免疫不全症やc型肝炎、その他の疾患の有病率の増加により、世界中で入院患者数が急増し、病院薬局の需要が増加しているためです。

北米は、臨床医の間で治療に対する需要が高まっていること、ヘルスケア支出が増加していること、大手企業が進出していることなどから、今後も最大地域であり続けると思われます。

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがあるか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の静注用免疫グロブリン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の静注用免疫グロブリン市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界の静注用免疫グロブリン市場：用途別
    • Hypogammaglobulinemia
    • CIPD
    • Immunodeficiency Diseases
    • Congenital AIDS
    • Chronic Lymphocytic Leukemia
    • Myasthenia Gravis
    • Multifocal Motor Neuropathy
    • Kawasaki Disease
    • Guillain-Barre Syndrome
  • 世界の静注用免疫グロブリン市場：流通チャネル別
    • 静脈内
    • 皮下
  • 世界の静注用免疫グロブリン市場：最終用途別
    • 病院
    • 在宅医療
    • 専門クリニック
    • その他
  • 世界の静注用免疫グロブリン市場：形態別
    • 液体
    • 凍結乾燥

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界の静注用免疫グロブリン市場：地域別
  • 北米の静注用免疫グロブリン市場
  • 欧州の静注用免疫グロブリン市場
  • アジア太平洋の静注用免疫グロブリン市場
  • その他の地域の静注用免疫グロブリン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 用途別の世界の静注用免疫グロブリン市場の成長機会
    • 流通チャネル別の世界の静注用免疫グロブリン市場の成長機会
    • 最終用途別の世界の静注用免疫グロブリン市場の成長機会
    • 形態別の世界の静注用免疫グロブリン市場の成長機会
    • 地域別の世界の静注用免疫グロブリン市場の成長機会
  • 世界の静注用免疫グロブリン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の静注用免疫グロブリン市場の生産能力拡大
    • 世界の静注用免疫グロブリン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Baxter
  • Bayer
  • Merck
  • Biotest
  • Top Bio
  • CSL
  • Octapharma
  • Grifols
  • Kedrion
  • Takeda Pharmaceuical
目次

Intravenous Immunoglobulin Trends and Forecast

The future of the global intravenous immunoglobulin market looks promising with opportunities in the hospital, homecare, and specialty clinic markets. The global intravenous immunoglobulin market is expected to reach an estimated $24.6 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing geriatric population, rising number of hemophiliacs, and new technologies related to the generation of immunoglobulin, and improved purification methods (with improved plasma yield).

A more than 150-page report is developed to help in your business decisions.

Intravenous Immunoglobulin by Segment

The study includes a forecast for the global intravenous immunoglobulin by application, distribution channel, end use, form, and region.

Intravenous Immunoglobulin Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Hypogammaglobulinemia
  • CIPD
  • Immunodeficiency Diseases
  • Congenital AIDs
  • Chronic Lymphocytic Leukemia
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Kawasaki Disease
  • Guillain-Barre Syndrome
  • Others

Intravenous Immunoglobulin Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Intravenous
  • Subcutaneous

Intravenous Immunoglobulin Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Intravenous Immunoglobulin Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Liquid
  • Lyophilized

Intravenous Immunoglobulin Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Intravenous Immunoglobulin Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous immunoglobulin companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous immunoglobulin companies profiled in this report include-

  • Baxter
  • Bayer
  • Merck
  • Biotest
  • Top Bio
  • CSL
  • Octapharma
  • Grifols
  • Kedrion
  • Takeda Pharmaceuical

Intravenous Immunoglobulin Market Insights

Lucintel forecasts that immunodeficiency diseases will remain the largest segment over the forecast period due to increasing focus towards the diagnosis and treatment based on individual patient and training of patients as most of the patients are not adaptable towards self administration.

Within this market, hospital will remain the largest segment due to the increasing prevalence of primary immunodeficiency and hepatitis c, as well as other diseases, has led to surge in hospitalizations around the world, thus increasing the demand for hospital pharmacies.

North America will remain the largest region due to growing demand of therapies among clinicians, rising healthcare expenditure, and presence of major players in the region.

Features of the Global Intravenous Immunoglobulin Market

Market Size Estimates: Intravenous immunoglobulin market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Intravenous immunoglobulin market size by various segments, such as by application, distribution channel, end use, form, and region in terms of value ($B).

Regional Analysis: Intravenous immunoglobulin market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications, distribution channels, end uses, forms, and regions for the intravenous immunoglobulin market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous immunoglobulin market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the intravenous immunoglobulin market size?

Answer: The global intravenous immunoglobulin market is expected to reach an estimated $24.6 billion by 2030.

Q.2 What is the growth forecast for intravenous immunoglobulin market?

Answer: The global intravenous immunoglobulin market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the intravenous immunoglobulin market?

Answer: The major drivers for this market are increasing geriatric population, rising number of hemophiliacs, and new technologies related to the generation of immunoglobulin, and improved purification methods (with improved plasma yield).

Q4. What are the major segments for intravenous immunoglobulin market?

Answer: The future of the global intravenous immunoglobulin market looks promising with opportunities in the hospital, homecare, and specialty clinic markets.

Q5. Who are the key intravenous immunoglobulin market companies?

Answer: Some of the key intravenous immunoglobulin companies are as follows:

  • Baxter
  • Bayer
  • Merck
  • Biotest
  • Top Bio
  • CSL
  • Octapharma
  • Grifols
  • Kedrion
  • Takeda Pharmaceuical

Q6. Which intravenous immunoglobulin market segment will be the largest in future?

Answer: Lucintel forecasts that immunodeficiency diseases will remain the largest segment over the forecast period due to increasing focus towards the diagnosis and treatment based on individual patient and training of patients as most of the patients are not adaptable towards self administration.

Q7. In intravenous immunoglobulin market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing demand of therapies among clinicians, rising healthcare expenditure, and presence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the intravenous immunoglobulin market by application (hypogammaglobulinemia, CIPD, immunodeficiency diseases, congenital aids, chronic lymphocytic leukemia, myasthenia gravis, multifocal motor neuropathy, kawasaki disease, guillain-barre syndrome, and others), distribution channel (intravenous and subcutaneous), end use (hospitals, homecare, specialty clinics, and others), form (liquid and lyophilized), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intravenous Immunoglobulin Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Intravenous Immunoglobulin Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Intravenous Immunoglobulin Market by Application
    • 3.3.1: Hypogammaglobulinemia
    • 3.3.2: CIPD
    • 3.3.3: Immunodeficiency Diseases
    • 3.3.4: Congenital AIDS
    • 3.3.5: Chronic Lymphocytic Leukemia
    • 3.3.6: Myasthenia Gravis
    • 3.3.7: Multifocal Motor Neuropathy
    • 3.3.8: Kawasaki Disease
    • 3.3.9: Guillain-Barre Syndrome
  • 3.4: Global Intravenous Immunoglobulin Market by Distribution Channel
    • 3.4.1: Intravenous
    • 3.4.2: Subcutaneous
  • 3.5: Global Intravenous Immunoglobulin Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Homecare
    • 3.5.3: Specialty Clinics
    • 3.5.4: Others
  • 3.6: Global Intravenous Immunoglobulin Market by Form
    • 3.6.1: Liquid
    • 3.6.2: Lyophilized

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Intravenous Immunoglobulin Market by Region
  • 4.2: North American Intravenous Immunoglobulin Market
    • 4.2.2: North American Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
  • 4.3: European Intravenous Immunoglobulin Market
    • 4.3.1: European Intravenous Immunoglobulin Market by Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, and Others
    • 4.3.2: European Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
  • 4.4: APAC Intravenous Immunoglobulin Market
    • 4.4.1: APAC Intravenous Immunoglobulin Market by Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, and Others
    • 4.4.2: APAC Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
  • 4.5: ROW Intravenous Immunoglobulin Market
    • 4.5.1: ROW Intravenous Immunoglobulin Market by Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, and Others
    • 4.5.2: ROW Intravenous Immunoglobulin Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Application
    • 6.1.2: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Intravenous Immunoglobulin Market by End Use
    • 6.1.4: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Form
    • 6.1.5: Growth Opportunities for the Global Intravenous Immunoglobulin Market by Region
  • 6.2: Emerging Trends in the Global Intravenous Immunoglobulin Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Intravenous Immunoglobulin Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intravenous Immunoglobulin Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter
  • 7.2: Bayer
  • 7.3: Merck
  • 7.4: Biotest
  • 7.5: Top Bio
  • 7.6: CSL
  • 7.7: Octapharma
  • 7.8: Grifols
  • 7.9: Kedrion
  • 7.10: Takeda Pharmaceuical